InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Up 39.7% in March

InnoCare Pharma Limited (OTCMKTS:INCPF) was the target of a large increase in short interest during the month of March. As of March 13th, there was short interest totaling 2,855,382 shares, an increase of 39.7% from the February 26th total of 2,044,382 shares. Based on an average daily volume of 600 shares, the short-interest ratio is presently 4,759.0 days.

InnoCare Pharma Price Performance

Shares of OTCMKTS:INCPF opened at $1.55 on Friday. InnoCare Pharma has a fifty-two week low of $1.55 and a fifty-two week high of $2.31. The business has a 50-day moving average of $1.80 and a two-hundred day moving average of $2.33.

About InnoCare Pharma

InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.

The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation.